Arthritis: Types, Symptoms, and Evidence-Based Management (2026)

Arthritis is the leading cause of disability in the United States — affecting more than 58 million American adults and over 350 million people worldwide. Yet it's widely misunderstood. Many people think arthritis is just "wear and tear" that comes with age, something you have to accept and live around. That's not the full picture. Understanding your specific type and the best available treatments can make a huge difference in pain, function, and quality of life.

Not All Arthritis Is the Same: The Key Types

Osteoarthritis (OA) — The Most Common

Osteoarthritis is a degenerative joint disease that affects an estimated 32.5 million Americans. It was long described purely as "wear and tear," but modern research shows it's more complex — involving inflammation, cartilage metabolism changes, and bone remodeling, not just mechanical breakdown.

In OA, the cartilage that cushions joint surfaces gradually breaks down. Bone rubs on bone, causing pain, stiffness, and reduced range of motion. The joints most commonly affected: knees, hips, spine, hands (particularly the base of the thumb and the end joints of fingers), and feet.

Risk factors: Age (most significant — prevalence rises sharply after 45), excess body weight (knee cartilage bears 4–6× body weight during walking; every extra kilogram adds significant stress), previous joint injury, occupational repetitive stress, genetics, and female sex (women develop OA more frequently and more severely than men).

Key symptom pattern: Joint pain that worsens with activity and improves with rest (early OA), morning stiffness lasting less than 30 minutes (longer stiffness suggests inflammatory arthritis), joint swelling and bony enlargement, crackling or grating sensation (crepitus), and reduced range of motion.

Rheumatoid Arthritis (RA) — The Autoimmune Form

Rheumatoid arthritis is a systemic autoimmune disease where the immune system attacks the synovium (the lining of joint membranes), causing inflammation that can ultimately destroy cartilage and bone. It affects about 1.5 million Americans — women 2–3 times more than men.

RA is a very different disease from OA. Key distinguishing features:

• Symmetrical joint involvement — both wrists, both knuckles simultaneously (OA is often asymmetric)
• Morning stiffness lasting more than 1 hour — a hallmark feature
• Systemic symptoms — fatigue, low-grade fever, weight loss, and malaise are common
• Smaller joints affected first — hands, wrists, and feet (OA more commonly affects knees and hips first)
• Extraarticular manifestations — RA can affect the lungs, heart, eyes, and blood vessels

Blood tests help confirm: Rheumatoid factor (RF) is positive in 70–80% of RA cases; anti-CCP antibodies are more specific (95% specificity) and may be positive years before symptoms develop. Elevated ESR and CRP indicate systemic inflammation.

Psoriatic Arthritis (PsA)

Affects up to 30% of people with psoriasis (the skin condition). It can present in several patterns — primarily affecting the small joints of fingers and toes (dactylitis — "sausage digits"), predominantly affecting the spine (spondylitis pattern), or resembling RA. Nail changes (pitting, ridging) are a helpful diagnostic clue.

Gout

A crystal arthritis caused by elevated uric acid levels that deposit as monosodium urate crystals in joints. Classic presentation: sudden, severe joint pain — classically in the big toe (podagra) — that peaks within 24 hours and typically resolves within 1–2 weeks. See our detailed gout guide for full coverage.

Ankylosing Spondylitis (AS)

An inflammatory arthritis primarily affecting the spine and sacroiliac joints. It predominantly affects young men (onset typically 20–40 years). Causes progressive fusion of spinal vertebrae, leading to reduced flexibility and, in severe cases, a rigid "bamboo spine." Morning stiffness that improves with movement (not rest) and low back pain in a young person should raise suspicion.

Osteoarthritis Management: What Actually Works

Exercise — The Most Important Non-Drug Treatment

This surprises many people: exercise is the most evidence-backed treatment for OA, particularly knee OA. A 2015 Cochrane review of 54 studies found that exercise significantly reduces pain and improves physical function in knee OA. The fear that exercise "wears out" cartilage is unfounded — cartilage actually requires movement-driven compression to receive nutrients (it has no blood supply).

Best types for OA: low-impact aerobic exercise (swimming, cycling, walking, water aerobics), strength training (particularly quadriceps strengthening for knee OA — strong muscles reduce joint load), and tai chi (multiple RCTs show it reduces knee pain and improves balance and psychological wellbeing).

Weight Management

For knee and hip OA, this is the single most impactful modifiable factor. Each kilogram of weight loss reduces knee joint loading by approximately 4 kilograms (due to biomechanical leverage). Losing 10% of body weight in overweight patients with knee OA reduces pain by 50% in many studies — comparable to strong analgesic medications.

Physical Therapy

A physical therapist can identify and address muscle imbalances, teach joint protection techniques, prescribe appropriate exercises, and provide manual therapy. Particularly valuable for hip OA and for improving functional mobility in severe knee OA.

Topical Treatments

Topical NSAIDs (diclofenac gel — Voltaren) are recommended as a first-line treatment for knee and hand OA by the American College of Rheumatology. They provide local anti-inflammatory effect with minimal systemic absorption — preferred over oral NSAIDs in older adults due to significantly lower cardiovascular and GI side effect risk.

Topical capsaicin (from chili peppers) — desensitizes nerve pain receptors over time. Must be applied consistently (3–4 times daily) for several weeks before full effect is seen. Initial burning sensation usually subsides after 1–2 weeks of regular use.

Oral Medications for OA

Acetaminophen (paracetamol) — for mild pain, though recent guidelines have downgraded its recommendation due to modest efficacy and potential liver risk with regular use.

Oral NSAIDs (ibuprofen, naproxen) — more effective than acetaminophen for OA pain, but carry GI (ulcers, bleeding), cardiovascular, and kidney risks — especially with long-term use. Use the lowest effective dose for the shortest necessary time. Take with food. Consider a PPI if long-term use is needed.

Duloxetine (Cymbalta) — an SNRI antidepressant with FDA approval for chronic musculoskeletal pain. Works through central pain pathways and can be useful when peripheral treatments are insufficient.

Intraarticular Injections

Corticosteroid injections — provide rapid pain relief (typically within days) lasting 4–12 weeks. Useful for managing flares and improving short-term function. Repeated injections (more than 3–4 per year per joint) may accelerate cartilage damage — use judiciously.

Hyaluronic acid (viscosupplementation) — injected into the knee joint; evidence is mixed. Some guidelines recommend it as an option for those who haven't responded to other treatments; others have withdrawn the recommendation. Discuss with your orthopedic surgeon.

Platelet-rich plasma (PRP) — growing evidence base, not yet universally recommended in guidelines. Some studies show benefit for knee OA, particularly in younger patients with milder disease.

Surgery

Total joint replacement — for severe OA that has significantly impaired quality of life despite optimal non-surgical management. Knee and hip replacements are among the most successful and cost-effective procedures in medicine — producing major pain relief and functional improvement in over 90% of patients. Average implant survival: 15–25 years, with newer designs lasting even longer.

Rheumatoid Arthritis: Treat to Target

The management of RA has been transformed over the past 25 years. The goal is now "treat to target" — achieving remission or low disease activity as early as possible to prevent irreversible joint damage. Early, aggressive treatment dramatically improves long-term outcomes.

DMARDs (Disease-Modifying Antirheumatic Drugs) are the backbone of RA treatment — they actually modify disease progression, not just manage symptoms. Methotrexate is the anchor DMARD, used in 70–80% of RA patients. Hydroxychloroquine and sulfasalazine are often added. Regular blood monitoring is required.

Biologics — when conventional DMARDs are insufficient, biologic agents targeting specific inflammatory pathways provide remarkable disease control: TNF inhibitors (adalimumab/Humira, etanercept/Enbrel), IL-6 inhibitors (tocilizumab), IL-17 inhibitors (secukinumab), JAK inhibitors (tofacitinib, baricitinib — oral, not injected). These have transformed RA from a crippling disease to one that most patients can manage while maintaining normal function.

Lifestyle Strategies for All Types of Arthritis

• Anti-inflammatory diet: Mediterranean diet pattern consistently shows benefits for RA and OA — rich in omega-3s, antioxidants, and polyphenols that reduce systemic inflammation. Our anti-inflammatory foods guide covers this in detail.
• Sleep optimization: Pain disrupts sleep; poor sleep amplifies pain — a vicious cycle. Treating sleep disorders directly improves arthritis pain perception.
• Heat and cold therapy: Heat (warm bath, heating pad) relaxes muscles and improves joint mobility — best before activity. Cold (ice pack, cold pack) reduces acute inflammation and swelling — best after activity or during flares.
• Assistive devices: Joint protection braces, shoe orthotics, walking aids, and grip aids reduce joint stress and improve function with no side effects.
• Mental health support: Chronic pain causes depression and anxiety — which in turn worsen pain perception. Cognitive behavioral therapy (CBT) for pain has strong evidence and should be part of comprehensive arthritis management.

Frequently Asked Questions